CAMP
CAMP4 Therapeutics Corporation - Common Stock (CAMP)
$72
About CAMP4 Therapeutics Corporation - Common Stock (CAMP)
CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Details
Daily high
$3.88
Daily low
$3.54
Price at open
$3.80
52 Week High
$7.75
52 Week Low
$2.90
Market cap
234.7M
Dividend yield
-
Volume
191,111
Avg. volume
134,062
P/E ratio
-1.68
CAMP4 Therapeutics Corporation - Common Stock News
Details
Daily high
$3.88
Daily low
$3.54
Price at open
$3.80
52 Week High
$7.75
52 Week Low
$2.90
Market cap
234.7M
Dividend yield
-
Volume
191,111
Avg. volume
134,062
P/E ratio
-1.68